Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.
Apply
JBI-802 & Pembrolizumab
A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step